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Abstract A highly efficient and catalyst-free protocol is reported for
the synthesis of quinoxalines via the classical cyclocondensation reac-
tion between aryldiamines and dicarbonyl compounds. Remarkably
simple and green reaction conditions employing methanol as solvent
afforded medium to excellent yield of quinoxalines after only one-min-
ute reaction time at ambient temperature. The conditions allow at least
10 gram scale synthesis of quinoxalines and should be a preferred start-
ing point for optimization and method of choice for applications in the
synthetic community.
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Quinoxaline is one of the truly important nitrogen-con-
taining heterocycles and versatile building blocks for the
synthesis of natural products, pharmaceutical agents,1 and
other biologically active compounds.2 The scaffold is linked
with a number of pharmacological activities such as anti-
cancer-,3 antifungal-,4 antiviral-,5 antimalarial-,6 antibacte-
rial-,7 and immunosuppressive/antineoplastic activities8
(Figure 1). Moreover, the quinoxaline scaffold is also em-
ployed in a range of applications as dyes,9 organic semicon-
ductors,10 anion receptors,11 dehydroannulenes,12 cav-
itands,13 electroluminescent materials,14 and DNA-cleaving
agents.15 Quinoxalines are central components of several
important antibiotics such as echinomycin, levomycin, and
actinoleutin.16
Figure 1  Some biologically important quinoxalines
The range of applications of quinoxalines has triggered
the development of numerous synthetic methods for their
synthesis.17 The direct condensation between 1,2-aryldi-
amines and 1,2-dicarbonyl compounds has been known
since the late 1800s and is, arguably, one of the most widely
known reactions in organic chemistry.17c,d A simple Scifind-
er search on the archetypical reaction between phenylene-
diamine and glyoxal reveals an astounding 48121 hits, truly
underlining the power and widespread knowledge of this
classical transformation. Some of the contemporary ap-
proaches towards quinoxalines also include the classical cy-
clocondensation and can be summarized as follows
(Scheme 1): (a) the condensation reaction between di-
amines and dicarbonyl compounds under reflux in ethanol
or acetonitrile with catalyst or acid present,18 (b) reaction
between vicinal diols and diamines in the presence of vari-
ety of metal catalysts and strong bases,19 (c) reaction with
-hydroxy ketones using MnO2 and CuCl2 as catalysts,
20 and
(d) the condensation of diamines with -halo ketones –
used for the synthesis of quinoxalines in the presence of
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V. Elumalai, J. H. Hansen LetterSynOpenThere are several improvements in synthetic procedures
reported using microwave irradiation,22 solid-phase syn-
thesis,23 ultrasound,24 as well as solvent-free25 and room-
temperature conditions.25 Numerous catalyst systems have
been reported for the synthesis of quinoxalines, including







um ammonium nitrate,36 gallium triflate,37 CuSO4·5H2O,
38
and sulfamic acid/methanol.39 In general, the reported
methods often require elevated temperatures, strong acid
catalyst, stoichiometric oxidant, expensive metal catalysts,
or relatively long reaction times to facilitate the reaction
with reasonable synthetic efficiency. Moreover, many of
these methods typically display low-atom economy and
yield undesirable byproducts. Thus, the development of
highly efficient, simple, and environmentally benign reac-
tion conditions is an important goal. In this regard, it can be
noted that roughly half of the Scifinder hits on the reaction
between phenylenediamine and glyoxal were classified as
uncatalyzed, i.e., occurred with only heating and/or pro-
longed reaction times. In this myriad of reported condi-
tions, it is difficult to navigate when considering the syn-
thesis of a specific quinoxaline. In this paper, we intend to
convey with clarity where to start.
It is often difficult to find a rationale for the use of all
the different catalysts and additives that have been report-
ed. However, it is well known that the condensation reac-
tion can be catalyzed by Lewis or Brønsted acids.18,19 More-
over, the shear diversity and quantity of reaction conditions
reported suggest that the condensation is very robust and
tolerant. With this perspective, we have aimed to overcome
typical limitations and to identify the most practical and
simple reaction conditions for this classical transformation
from which any optimization work should start. Herein, we
demonstrate a very simple, high-yielding/highly atom-eco-
nomic protocol for the synthesis of quinoxalines using di-
amines and dicarbonyl compounds in methanol as solvent
at room temperature with only one-minute reaction time.
To our surprise, previous accounts have not described the
broad use and scope of the very simplest conditions for the
synthesis of quinoxalines.
We have recently published a rapid method for the syn-
thesis of benzimidazoles40 using only methanol as solvent
at room temperature with one-minute reaction time. The
unprecedented simplicity and efficiency of this system be-
came the impetus for our current study, in which we inves-
tigate the synthesis of quinoxalines via 1,2-dicarbonyl com-
pounds under similar experimental conditions. By mixing
the reagents in 5 mL/mmol methanol at room temperature
for one minute in a vessel open to air, the reaction between
phenylenediamine 1a and glyoxal 2a gave impressive 99%
GC conversion and 93% isolated yield of quinoxaline 3a (Ta-
ble 1).41 The same reaction in ethanol also gave quantitative
GC conversion, but somewhat less 85% isolated yield of 3a.
A survey of other solvents revealed that a broad spectrum
of reaction media can be employed, and 99% GC conversions
were observed in acetonitrile, DMF, THF, ethyl acetate, and
chloroform. There seems to be a consistent relation be-
tween the GC conversions and isolated yields.
Table 1  Solvent Screen for Quinoxaline Formation at One-Minute 
Reactiona
Only acetone and water gave lowered conversions in
this assay (77% and 60%, respectively) which appeared to be
due to solubility problems in these solvents. The reaction is
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Medium to excellent yield




4 EtOH 99 (85)c
5 MeOH 99 (93)c





a Reaction procedure: to a stirred solution of diamine 1 (100 mg, 0.925 
mmol) in a specified solvent (5 mL), glyoxal 2 (40%, 0.11 mL, 0.925 mmol) 
was added and stirred for 1 min at ambient temperature.
b GC conversion of starting material.
c Isolated yield.
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periment with doubled amount of methanol (10 mL mmol–
1) afforded the same full conversion and an only slightly di-
minished isolated yield of 88% after one-minute reaction
time. Thus, the amount of solvent employed can probably
be minimized but 5 mL mmol–1 was kept as standard for
practical reasons. Based on this survey, the further studies
were conducted in methanol although it should be noted
that a range of solvents are viable.
We next studied various systems with different substit-
uents on the diamine and the dicarbonyl components in or-
der to ascertain the generality of the simple reaction condi-
tions (Scheme 2). Adding methyl groups, using either bu-
tane-2,3-dione or 4,5-dimethylphenylenediamine or both
as the electrophile, did not significantly alter the outcome
of the corresponding condensation products 3a–d which
were formed in excellent 93–96% yields. Introducing halo-
gens on the diamine, such as 3k,l led to diminished but still
good yields (62–66%). The 7-bromo-5-chloro-disubstituted
product 3e was also formed in similar yield (65%), whereas
6,7-dichloroquinoxaline (3g) was formed in 40% yield. Fur-
ther tests with butane-2,3-dione and the dihalogenated di-
amines also displayed diminished yields in this series (29–
55% yields). Compound 3f was formed in the lowest yield
(29%) and even increasing the reaction time up to 30 min-
utes did not alter this outcome. The main problem appears
to be that conversion of the starting material stops or be-
comes very slow (from GC analyses). The case of 3g was
studied further to find a solution for improving the yields
observed in the dihalogenated systems. Upon heating the
reaction mixture in a microwave at 100 °C for 5 minutes,
full conversion was observed, and 91% yield of 3g was iso-
lated. Thus, heating is one effective solution, however, we
were invested in finding as simple conditions as possible for
rapid conversion into product. Conducting the reaction in
acetic acid as solvent also gave full conversion of the start-
ing material and 85% yield of 3g was isolated after one-min-
ute reaction. This also suggests, not surprisingly, that the
yield can be enhanced by acid catalysis, which was con-
firmed by an experiment in methanol adding 10 mol% of
acetic acid, which also gave full conversion and comparable
82% isolated yield of 3g. The formation of product 3f was
vastly improved to 98% yield upon microwave irradiation at
100 °C for 10 minutes. There seems to be several possible
strategies for improving low-yielding cases while maintain-
ing very short reaction times.
Interestingly, with butane-2,3-dione and monohaloge-
nated diamines, the products 3j and 3m were formed in
very high 87% and 98% yields, respectively. Moreover, the 6-
cyanosubstituted system 3n was formed in 90% yield. A
synergetic electronic combination may occur in these par-
ticular systems ensuring rapid transformations. Further, di-
aryl diketones were briefly explored, and 3o was formed in
near quantitative yield. The dimethyl and monochloro sys-
tems 3p,q were also formed in excellent 91% and 89% yields,
respectively, whereas the monobromo system yielded only
moderate amounts of 3r (51%). The chemistry is also com-
patible with substitution on the aryl diketone part, as the
ortho-chlorosubstituted variant yielded 3s in 80% isolated
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3e (65%)i 3f (29%)b (98%)h
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[a] Reaction Procedure: To a stirred solution of diamine 1 (0.925 mmol) in MeOH (5 mL), 
dicarbonyl compound 2 (0.925 mmol) was added and stirred for one minute at ambient 
temperature. Yields of crude material are reported for high-purity products, unless otherwise 
noted.
[b] GC-yield. Similar GC-yield was obtained even with prolonged reaction time up to 30 minutes.
[c] Reaction done at 100 °C in microwave reactor for 5 mins. 99% GC-conversion was observed.
[d] Reaction done at rt in AcOH for one minute. 99% GC-conversion was observed.
[e] Reaction done at rt in MeOH with 10 mol% of AcOH for one minute. 99% GC-conversion was 
observed.
[f] Mixture of isomers (1:1 ratio) was observed under the reaction conditions.
[g] NMR yield.
[h] Reaction done at 100 °C in microwave reactor for 10 min.
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crowded electrophiles. Next, heteroaryl diketones were em-
ployed with 2-furyl and 2-pyridyl substituents. These
worked excellently to generate fairly complex multihet-
eroaromatic systems 3t–w in 75–96% yields. Finally, some
unsymmetrical combinations were tested and 5-benzoyl-
phenylenediamine in combination with 1,2-propanedione
yielded excellent 96% of products 3x/3x′ as an equimolar
isomeric mixture. An equimolar isomeric mixture was also
observed with 1-phenyl-1,2-propanedione as electrophile,
and 91% yield was isolated of 3y and 3y′. Lastly, 4,5-dimeth-
ylphenylenediamine was employed with indoyl-substituted
oxocarboxylic acid 2z to generate the 2-hydroxy-3-(3-in-
doyl)-substituted quinoxaline 3z in moderate 41% yield
(NMR). The yield was substantially improved upon micro-
wave irradiation to 79%. In this case, one of the electrophilic
sites is a carboxylic acid, and the diminished electrophilici-
ty is likely the reason for the attenuated reactivity. In gener-
al, all products appeared to be stable upon isolation and
storage, so this cannot explain any diminished chemical
yields. The compounds 3f, 3y, and 3z are novel molecules.42
Overall, the rapid quinoxaline formation appears to have
rather broad scope with good to excellent yields obtainable
in most cases and with temperature increase or simple acid
catalysis as strategies to boost yields in problematic cases.
Based on the results herein, and a comparison with
many of the literature studies employing various catalysts,
heating, and prolonged reaction times, it is tempting to
conclude that many studies lack an important control ex-
periment without added catalyst. Moreover, prolonged re-
action times and the need for heating of simple substrates
may even suggest that the ‘catalysts’ employed in some cas-
es actually decrease the reaction rates. This could occur if a
metal predominantly coordinates with one or both of the
substrates and thus, would reduce the effective concentra-
tion of reacting species and require more time or energy to
effect an acceptable reaction outcome.
Based on these considerations and the results in this pa-
per, we would like to strongly advocate that synthetic stud-
ies of quinoxaline formation using the classical condensa-
tion reaction should commence with the simple conditions
described herein and that any novel catalytic reactions
should be compared directly to the ‘uncatalyzed’ counter-
part to assess the true catalyst performance. Lastly, it
should be widely known and intuitive for practicing syn-
thetic chemists that this classical condensation reaction can
occur in minutes and without addition of catalysts. This
does not appear to be the case upon examination of the lit-
erature.
In order to demonstrate further the applicability of
these reaction conditions, five examples were conducted in
experiments on larger scales (Scheme 3).41 Compounds 3,
3o, and 3w were generated in high to excellent yields (91%,
70%, and 94% respectively) at 1 g scale using the basic con-
ditions and methanol as solvent. If the reaction solvent was
ethyl acetate, this would streamline the workup consider-
ably since removal of the reaction solvent becomes unnec-
essary. Thus, we conducted the reaction at 10 g scale in eth-
yl acetate and quinoxalines 3a and 3 were readily isolated
in impressive 93% and 85% yields, respectively. This study
strongly suggests that this should be a method of choice for
the construction of such structures on scale.
Scheme 3  Scale-up of the quinoxaline synthesis
In summary, we have revisited a classical transforma-
tion and report on improved synthesis efficiency and
broadened scope of quinoxaline formation via the rapid
condensation between aryldiamines and 1,2-dicarbonyl
compounds. The cyclocondensation occurs fast under re-
markably simple reaction conditions in medium to excel-
lent chemical yields. Using methanol as solvent, the reac-
tion typically proceeds at room temperature, open to air,
and with only 1 minute reaction time. Problematic cases
can be solved with simple acid catalysis or heating while
maintaining very short reaction times. The practical nature
and scalability of this green approach makes it an obvious
starting point and method-of-choice for the synthesis of a
range of quinoxalines.
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[a] Reaction Scale-up Procedure: To a stirred solution of diamine 1 (1 g) 
in MeOH (50 mL), dicarbonyl compound (symmetrical) 2  was added and 
stirred for 1 minute at ambient temperature.
Crude yields after work-up have been reported. [b] Isolated yield.
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without column purification (GC purity >99%). 1H NMR (400
MHz, CDCl3):  = 8.84 (s, 2 H), 8.11 (dd, J = 6.4, 3.5 Hz, 2 H), 7.78
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CDCl3):  = 195.7, 157.1, 157.0, 154.1, 153.6, 148.7, 148.7, 142.9,
140.2, 138.8, 137.1, 136.8, 136.8, 132.9, 132.5, 130.4, 130.2,
129.9, 128.6, 124.4, 124.2, 123.4, 123.3.
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to demonstrate the purity of the products after the indicated
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